Skip to main content

Vincerx Pharma, Inc.

VINCDelisted Apr 28, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001796129

Vincerx Pharma, Inc. was delisted on Apr 28, 2025; its insiders filed their last Form 4 on Aug 14, 2024; 14 institutions reported holding it in 13F filings for Q1 2025, worth $116.8K in total; no superinvestor held it.

13F holders, Q1 2024

Institutional positions in Vincerx Pharma, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
38
+6 vs. Q4 2023
Shares held
8.46M
−1.38M (−14.0%) vs. Q4 2023
Total value
$42.7M
+$31.1M (+268.4%) vs. Q4 2023
New holders
12
8 more added
Sold out
6
12 more reduced

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VINC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 38 institutions
Q1 2021: 36 institutionsQ2 2021: 56 institutionsQ3 2021: 55 institutionsQ4 2021: 55 institutionsQ1 2022: 65 institutionsQ2 2022: 49 institutionsQ3 2022: 43 institutionsQ4 2022: 34 institutionsQ1 2023: 35 institutionsQ2 2023: 34 institutionsQ3 2023: 35 institutionsQ4 2023: 33 institutionsQ1 2024: 38 institutionsQ2 2024: 28 institutionsQ3 2024: 26 institutionsQ4 2024: 21 institutionsQ1 2025: 14 institutionsQ2 2025: 1 institutionQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2024: $42.7M
Q1 2021: $171.0MQ2 2021: $157.3MQ3 2021: $248.9MQ4 2021: $156.8MQ1 2022: $65.1MQ2 2022: $18.4MQ3 2022: $20.0MQ4 2022: $13.0MQ1 2023: $13.3MQ2 2023: $15.7MQ3 2023: $10.8MQ4 2023: $11.6MQ1 2024: $42.7MQ2 2024: $8.66MQ3 2024: $7.89MQ4 2024: $1.26MQ1 2025: $116.8KQ2 2025: $2Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding VINC and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20251$2
Q1 202514$116.8K
Q4 202421$1.26M
Q3 202426$7.89M
Q2 202428$8.66M
Q1 202438$42.7M
Q4 202333$11.6M
Q3 202335$10.8M
Q2 202334$15.7M
Q1 202335$13.3M
Q4 202234$13.0M
Q3 202243$20.0M
Q2 202249$18.4M
Q1 202265$65.1M
Q4 202155$156.8M
Q3 202155$248.9M
Q2 202156$157.3M
Q1 202136$171.0M

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Vincerx Pharma, Inc.; share changes are against Q4 2023.

Institutions holding VINC in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Sage Rhino Capital LLC1,703,413$8.62M2.03%00.0%Unchanged
Octagon Capital Advisors LP1,000,000$5.06M0.62%+1,000,000New
Point72 Asset Management, L.P.954,827$4.83M0.01%+610,000+176.9%Added
Rock Springs Capital Management LP891,719$4.51M0.11%00.0%Unchanged
Bank of America Corp701,423$3.55M0.00%−381,440−35.2%Reduced
Vanguard Group Inc666,995$3.37M0.00%+153,575+29.9%Added
Goldman Sachs Group Inc631,490$3.20M0.00%−1,078,166−63.1%Reduced
Kingdon Capital Management, L.L.C.385,000$1.95M0.26%00.0%Unchanged
ExodusPoint Capital Management, LP316,642$1.60M0.02%−7,477−2.3%Reduced
Geode Capital Management, LLC182,483$923.7K0.00%+28,452+18.5%Added
Citadel Advisors LLC178,240$901.9K0.00%−19,119−9.7%Reduced
Renaissance Technologies LLC121,400$614.0K0.00%−54,620−31.0%Reduced
Rubric Capital Management LP116,873$591.4K0.02%−237,504−67.0%Reduced
Sio Capital Management, LLC102,049$516.4K0.18%00.0%Unchanged
Eversept Partners, LP79,588$402.7K0.03%+79,588New
Marshall Wace, LLP71,566$362.1K0.00%+71,566New
State Street Corp57,016$288.5K0.00%+13,873+32.2%Added
BlackRock Inc.47,080$238.2K0.00%−17,179−26.7%Reduced
Northern Trust Corp34,325$173.7K0.00%+8,711+34.0%Added
Price T Rowe Associates Inc30,000$152.0K0.00%−10,000−25.0%Reduced
Jane Street Group, LLC29,318$148.3K0.00%+29,318New
Millennium Management LLC25,944$131.3K0.00%−8,524−24.7%Reduced
Woodline Partners LP23,645$119.6K0.00%+23,645New
Morgan Stanley19,627$99.3K0.00%+1,872+10.5%Added
Vontobel Holding Ltd.15,000$75.9K0.00%+15,000New
LPL Financial LLC13,770$69.7K0.00%+13,770New
American Century Companies Inc11,789$59.7K0.00%+11,789New
LMR Partners LLP10,000$50.6K0.00%00.0%Unchanged
Cresset Asset Management, LLC10,000$50.6K0.00%+10,000New
Acadian Asset Management LLC5,259$26.0K0.00%−36,571−87.4%Reduced
Tower Research Capital LLC (TRC)4,541$23.0K0.00%−808−15.1%Reduced
UBS Group AG2,498$12.6K0.00%−451−15.3%Reduced
Qube Research & Technologies Ltd2,477$12.5K0.00%+2,473+61,825.0%Added
Colony Group, LLC10,900$10.0K0.00%+10,900New
ICA Group Wealth Management, LLC300$1.52K0.00%+300New
Wells Fargo & Company160$8100.00%+27+20.3%Added
Barclays PLC23$1160.00%00.0%Unchanged
Macquarie Group Ltd266$10.00%+266New
Long Focus Capital Management, LLC0$00.00%−1,098,753−100.0%Sold out
Tejara Capital Ltd0$00.00%−233,348−100.0%Sold out
Walleye Capital LLC0$00.00%−115,044−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−114,000−100.0%Sold out
Marex Group plc0$00.00%−49,404−100.0%Sold out
FMR LLC0$00.00%−6−100.0%Sold out
Wade G W & Inc––––Not filed